Company intelligence / Profile preview

MediMergent

Rockville, Maryland, United Statesmedimergent.com ↗

Ownership: Private
Employees: ~52
Development stage: Other

Overview

MediMergent provides advanced digital platforms to collect, integrate, and analyze real-world data with a focus on the "Voice of the Patient." Their technology is used in large-scale studies such as EIMPRIS to improve patient engagement, track outcomes, monitor adverse events, and support regulatory submissions. They partner with organizations like the FDA to enhance medication adherence monitoring.

Therapeutic areas: OtherOncology
Modalities: Non-pharmacological therapy (digital platform for patient engagement and RWE)Device (digital apps/platforms)
Industry: Digital Health Medical Devices

Partnerships

U.S. Food & Drug Administration Center for Drug Evaluation & ResearchAON as sponsor of EIMPRIS trial

Beyond the preview

Go deeper on MediMergent.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MediMergent.

Explore the full profile